Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Effects of ShenLing BaiZhu San Supplementation on Gut Microbiota and Oxidative Stress in Rats with Ulcerative Colitis. ✅
Go to Publication ✅
Evidence-based complementary and alternative medicine : eCAM (Evid Based Complement Alternat Med ) Vol: 2021 Issue Pages: 3960989 Pub: 2021 Epub: 2021 Oct 1 Authors Gu D , Zhou S , Yao L , Tan Y , Chi X , Shi D , Guo S , Liu C , |
|
|
Effects of ShenLing BaiZhu San Supplementation on Gut Microbiota and Oxidative Stress in Rats with Ulcerative Colitis. ✅
Go to Publication ✅
Evidence-based complementary and alternative medicine : eCAM (Evid Based Complement Alternat Med ) Vol: 2021 Issue Pages: 3960989 Pub: 2021 Epub: 2021 Oct 1 Authors Gu D , Zhou S , Yao L , Tan Y , Chi X , Shi D , Guo S , Liu C , |
|
|
Effects of ShenLing BaiZhu San Supplementation on Gut Microbiota and Oxidative Stress in Rats with Ulcerative Colitis. ✅
Go to Publication ✅
Evidence-based complementary and alternative medicine : eCAM (Evid Based Complement Alternat Med ) Vol: 2021 Issue Pages: 3960989 Pub: 2021 Epub: 2021 Oct 1 Authors Gu D , Zhou S , Yao L , Tan Y , Chi X , Shi D , Guo S , Liu C , |
|
|
Systems Pharmacology and Microbiome Dissection of Shen Ling Bai Zhu San Reveal Multiscale Treatment Strategy for IBD. ✅
Go to Publication ✅
Oxidative medicine and cellular longevity (Oxid Med Cell Longev ) Vol: 2019 Issue Pages: 8194804 Pub: 2019 Epub: 2019 Jun 23 Authors Lv WJ , Liu C , Li YF , Chen WQ , Li ZQ , Li Y , Xiong Y , Chao LM , Xu XL , Guo SN , |
|
|
Systems Pharmacology and Microbiome Dissection of Shen Ling Bai Zhu San Reveal Multiscale Treatment Strategy for IBD. ✅
Go to Publication ✅
Oxidative medicine and cellular longevity (Oxid Med Cell Longev ) Vol: 2019 Issue Pages: 8194804 Pub: 2019 Epub: 2019 Jun 23 Authors Lv WJ , Liu C , Li YF , Chen WQ , Li ZQ , Li Y , Xiong Y , Chao LM , Xu XL , Guo SN , |
|
|
Systems Pharmacology and Microbiome Dissection of Shen Ling Bai Zhu San Reveal Multiscale Treatment Strategy for IBD. ✅
Go to Publication ✅
Oxidative medicine and cellular longevity (Oxid Med Cell Longev ) Vol: 2019 Issue Pages: 8194804 Pub: 2019 Epub: 2019 Jun 23 Authors Lv WJ , Liu C , Li YF , Chen WQ , Li ZQ , Li Y , Xiong Y , Chao LM , Xu XL , Guo SN , |
|
|
Systems Pharmacology and Microbiome Dissection of Shen Ling Bai Zhu San Reveal Multiscale Treatment Strategy for IBD. ✅
Go to Publication ✅
Oxidative medicine and cellular longevity (Oxid Med Cell Longev ) Vol: 2019 Issue Pages: 8194804 Pub: 2019 Epub: 2019 Jun 23 Authors Lv WJ , Liu C , Li YF , Chen WQ , Li ZQ , Li Y , Xiong Y , Chao LM , Xu XL , Guo SN , |
|
|
Systems Pharmacology and Microbiome Dissection of Shen Ling Bai Zhu San Reveal Multiscale Treatment Strategy for IBD. ✅
Go to Publication ✅
Oxidative medicine and cellular longevity (Oxid Med Cell Longev ) Vol: 2019 Issue Pages: 8194804 Pub: 2019 Epub: 2019 Jun 23 Authors Lv WJ , Liu C , Li YF , Chen WQ , Li ZQ , Li Y , Xiong Y , Chao LM , Xu XL , Guo SN , |
|
|
Shen-Ling-Bai-Zhu-San alleviates functional dyspepsia in rats and modulates the composition of the gut microbiota. ✅
Go to Publication ✅
Nutrition research (New York, N.Y.) (Nutr Res ) Vol: 71 Issue Pages: 89-99 Pub: 2019 Nov Epub: 2019 Oct 29 Authors Zhang S , Lin L , Liu W , Zou B , Cai Y , Liu D , Xiao D , Chen J , Li P , Zhong Y , Liao Q , Xie Z , |
|
|
Shen-Ling-Bai-Zhu-San alleviates functional dyspepsia in rats and modulates the composition of the gut microbiota. ✅
Go to Publication ✅
Nutrition research (New York, N.Y.) (Nutr Res ) Vol: 71 Issue Pages: 89-99 Pub: 2019 Nov Epub: 2019 Oct 29 Authors Zhang S , Lin L , Liu W , Zou B , Cai Y , Liu D , Xiao D , Chen J , Li P , Zhong Y , Liao Q , Xie Z , |
|
|
Shen-Ling-Bai-Zhu-San (SL) and SL Derived-Polysaccharide (PL) Ameliorate the Severity of Diarrhea-Induced by High Lactose via Modification of Colonic Fermentation. ✅
Go to Publication ✅
Frontiers in pharmacology (Front Pharmacol ) Vol: 13 Issue Pages: 883355 Pub: 2022 Epub: 2022 Jun 28 Authors Xue H , Ma J , Wang Y , Lu M , Wang F , Tang X , |
|
|
Shen-Ling-Bai-Zhu-San alleviates the imbalance of intestinal homeostasis in dextran sodium sulfate-induced colitis mice by regulating gut microbiota and inhibiting the NLRP3 inflammasome activation. ✅
Go to Publication ✅
Journal of ethnopharmacology (J Ethnopharmacol ) Vol: 319 Issue Pt 1 Pages: 117136 Pub: 2024 Jan 30 Epub: 2023 Sep 11 Authors Gao Q , Tian W , Yang H , Hu H , Zheng J , Yao X , Hu B , Liu H , |
|
|
Shen-Ling-Bai-Zhu-San alleviates the imbalance of intestinal homeostasis in dextran sodium sulfate-induced colitis mice by regulating gut microbiota and inhibiting the NLRP3 inflammasome activation. ✅
Go to Publication ✅
Journal of ethnopharmacology (J Ethnopharmacol ) Vol: 319 Issue Pt 1 Pages: 117136 Pub: 2024 Jan 30 Epub: 2023 Sep 11 Authors Gao Q , Tian W , Yang H , Hu H , Zheng J , Yao X , Hu B , Liu H , |
|
|
Shen-ling-bai-zhu-san ameliorates inflammation and lung injury by increasing the gut microbiota in the murine model of Streptococcus pneumonia-induced pneumonia. ✅
Go to Publication ✅
BMC complementary medicine and therapies (BMC Complement Med Ther ) Vol: 20 Issue 1 Pages: 159 Pub: 2020 May 27 Epub: 2020 May 27 Authors Feng J , Dai W , Zhang C , Chen H , Chen Z , Chen Y , Pan Q , Zhou Y , |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]
